Total planned funding: $247,171,054
Allocations
Countries/Regions
Eswatini | $247,171,054 |
Organizational Types
Private Contractor | $53,335,976 |
Unknown | $51,113,410 |
NGO | $49,463,104 |
University | $45,601,572 |
Own Agency | $28,118,702 |
Host Country Government Agency | $7,383,459 |
FBO | $6,188,454 |
Multi-lateral Agency | $3,366,724 |
Other USG Agency | $1,790,053 |
Implementing Agency | $809,600 |
Program Areas
Care | $74,417,148 |
Prevention | $50,887,018 |
Treatment | $48,943,803 |
Governance and Systems | $34,846,558 |
Testing | $21,317,271 |
Management and Operations | $16,759,256 |
Budget Codes
HTXS: Treatment: Adult Treatment | $39,679,224 |
HBHC: Care: Adult Care and Support | $32,701,820 |
HKID: Care: Orphans and Vulnerable Children | $22,260,169 |
HVCT: Testing: HIV Testing and Counseling | $21,317,271 |
HVSI: Strategic Information | $20,077,253 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,497,324 |
HVMS: Management and Operations | $16,759,256 |
HVTB: Care: TB/HIV | $12,874,919 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,413,104 |
OHSS: Health Systems Strengthening | $11,009,904 |
HVOP: Sexual Prevention: Other Sexual Prevention | $10,432,616 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,968,974 |
PDCS: Care: Pediatric Care and Support | $6,580,240 |
HTXD: Treatment: ARV Drugs | $5,062,964 |
PDTX: Treatment: Pediatric Treatment | $4,201,615 |
HLAB: Laboratory Infrastructure | $3,759,401 |
HMBL: Biomedical Prevention: Blood Safety | $1,575,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$46,714,424
Countries/Regions
Columbia University:
$36,609,037
Countries/Regions
Pact, Inc.:
$27,415,961
Countries/Regions
USG Aggregated Agencies:
$16,189,354
Countries/Regions